TriMas (NASDAQ:TRS) Lowered to Strong Sell Rating by Zacks Research

TriMas (NASDAQ:TRSGet Free Report) was downgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued on Thursday,Zacks.com reports.

Other equities research analysts also recently issued research reports about the company. Wall Street Zen downgraded TriMas from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. BWS Financial reissued a “buy” rating and set a $45.00 price target on shares of TriMas in a research report on Monday, March 2nd. Weiss Ratings reissued a “hold (c+)” rating on shares of TriMas in a report on Monday, December 29th. Finally, KeyCorp restated an “overweight” rating and set a $38.00 price target on shares of TriMas in a report on Thursday, February 26th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, TriMas currently has an average rating of “Hold” and a consensus price target of $41.50.

View Our Latest Analysis on TRS

TriMas Stock Down 3.2%

TRS stock opened at $37.44 on Thursday. The stock’s 50 day moving average is $35.88 and its 200-day moving average is $36.05. The firm has a market capitalization of $1.41 billion, a PE ratio of 12.61 and a beta of 0.55. The company has a quick ratio of 1.42, a current ratio of 2.52 and a debt-to-equity ratio of 0.66. TriMas has a twelve month low of $19.45 and a twelve month high of $42.00.

TriMas (NASDAQ:TRSGet Free Report) last posted its quarterly earnings data on Thursday, February 26th. The industrial products company reported $0.40 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.41 by ($0.01). TriMas had a return on equity of 12.04% and a net margin of 11.53%.The company had revenue of $155.49 million for the quarter, compared to analysts’ expectations of $192.96 million. During the same quarter last year, the business posted $0.43 EPS. The business’s quarterly revenue was up 12.4% on a year-over-year basis. Sell-side analysts expect that TriMas will post 1.69 EPS for the current fiscal year.

Hedge Funds Weigh In On TriMas

Several institutional investors have recently added to or reduced their stakes in the company. Mariner LLC grew its holdings in shares of TriMas by 2.2% during the 3rd quarter. Mariner LLC now owns 19,536 shares of the industrial products company’s stock valued at $755,000 after acquiring an additional 414 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH raised its holdings in TriMas by 8.1% in the 3rd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 8,693 shares of the industrial products company’s stock worth $336,000 after acquiring an additional 654 shares during the period. Ellevest Inc. increased its position in TriMas by 11.6% in the 4th quarter. Ellevest Inc. now owns 6,418 shares of the industrial products company’s stock worth $228,000 after buying an additional 669 shares during the period. Los Angeles Capital Management LLC acquired a new position in TriMas during the 4th quarter valued at $29,000. Finally, Covestor Ltd increased its stake in TriMas by 20,525.0% during the fourth quarter. Covestor Ltd now owns 825 shares of the industrial products company’s stock valued at $29,000 after acquiring an additional 821 shares during the period. Hedge funds and other institutional investors own 99.42% of the company’s stock.

About TriMas

(Get Free Report)

TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.

The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.

Featured Stories

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.